Home Newsfeeds Instil Bio Q3 EPS $(0.43) Down From $(0.33) YoY

Instil Bio Q3 EPS $(0.43) Down From $(0.33) YoY

Instil Bio (NASDAQ:TIL) reported quarterly losses of $(0.43) per share. This is a 30.3 percent decrease over losses of $(0.33) per share from the same period last year.

byBenzinga Newsdesk

November 14, 2022

1 minute read

Instil Bio (NASDAQ:TIL) reported quarterly losses of $(0.43) per share. This is a 30.3 percent decrease over losses of $(0.33) per share from the same period last year.

Wells Fargo Maintains Overweight on Flywire, Raises Price Target to $30

By Benzinga Newsdesk

January 9, 11:12 AM

Wells Fargo analyst Jeff Cantwell maintains Flywire (NASDAQ:FLYW) with a Overweight and raises the price target from $27 to $30.

FLYW

Adaptive Biotechnologies Names New CFO Preserves Strong Capital Position

By Vandana Singh

April 3, 1:42 PM

Adaptive Biotechnologies announces strategic restructuring to enhance independence and financial strength.

ADPT

Concerns Over Tinder’s Prospects Despite Match’s Multiple Catalysts Keeps Analyst At Sidelines

By Anusuya Lahiri

January 26, 1:15 PM

Citigroup analyst Ygal Arounian initiated coverage on Match Group Inc (NASDAQ:MTCH) with a Neutral rating and a price target of $55. Match…

MTCH

If You Invested $100 In This Stock 15 Years Ago, You Would Have $400 Today

By Benzinga Insights

November 2, 11:58 AM

Marriott Intl (NASDAQ:MAR) has outperformed the market over the past 15 years by 3.64% on an annualized basis producing an average annual return of 10.21%. Currently, Marriott Intl has a market capitalization of $51.05 billion.

MAR

Instil Bio Q3 EPS $(0.43) Down From $(0.33) YoY

Related Posts

Wells Fargo Maintains Overweight on Flywire, Raises Price Target to $30

Adaptive Biotechnologies Names New CFO Preserves Strong Capital Position

Concerns Over Tinder’s Prospects Despite Match’s Multiple Catalysts Keeps Analyst At Sidelines

If You Invested $100 In This Stock 15 Years Ago, You Would Have $400 Today